New Data Demonstrates >90% Year 1 Success Rate for Radiofrequency Ablation in Treating Patients with Atrial Fibrillation

Published data from the Journal of American College of Cardiology: Clinical Electrophysiology showcased at the 15th edition of Venice Arrhythmias 2017 BRUSSELS, Nov. 22, 2017 /PRNewswire/ -- Biosense Webster, a Division of Johnson & Johnson Medical NV/SA, and a leader in the...

from PR Newswire: //www.prnewswire.co.uk/news-releases/new-data-demonstrates-90-year-1-success-rate-for-radiofrequency-ablation-in-treating-patients-with-659255503.html